Efficient Catalyst for the Suzuki−Miyaura Coupling of Potassium Aryl Trifluoroborates with Aryl Chlorides
作者:Timothy E. Barder、Stephen L. Buchwald
DOI:10.1021/ol0491686
日期:2004.8.1
Palladium-catalyzed Suzuki-Miyaura cross-coupling reactions of aryl- and heteroaryl chlorides with potassium aryl- and heteroaryltrifluoroborates have been accomplished with the supporting ligand S-Phos in good to excellent yield. Hindered biaryls and substrates containing a variety of functional groups can be prepared. Suzuki-Miyaura couplings of a 3-pyridyl boron-based nucleophile with aryl- and
A Versatile Method for Suzuki Cross-Coupling Reactions of Nitrogen Heterocycles
作者:Noriaki Kudo、Mauro Perseghini、Gregory C. Fu
DOI:10.1002/anie.200503479
日期:2006.2.13
Experimental and Computational Probes of a Self-Assembled Capsule
作者:Tetsuo Iwasawa、Dariush Ajami、Julius Rebek
DOI:10.1021/ol0607600
日期:2006.7.1
This research was undertaken to explore the interior surface of a synthetic receptor 1.1 with arylpyridines as guests. The interior surface differentiates the guests through the recognition of their nitrogen atoms. Experimental and computational analyses revealed that there is a delicate balance of attractions and repulsions between the host and the lone pairs of guests.
BISPHOSPHONATE COMPOUNDS AND METHODS FOR BONE RESORPTION DISEASES, CANCER, BONE PAIN, IMMUNE DISORDERS, AND INFECTIOUS DISEASES
申请人:THE BOARD OF TRUSTEES
OF THE UNIVERSITY OF ILLINOIS
公开号:EP1802641B1
公开(公告)日:2011-08-10
LINCOSAMIDE ANTIBIOTICS AND USES THEREOF
申请人:President and Fellows of Harvard College
公开号:US20200339620A1
公开(公告)日:2020-10-29
Provided are lincosamide compounds for the treatment of infectious diseases. The lincosamides described herein are modified at the amino acid (southern) region. The lincosamides may have further modification at the C-1 and C-7 positions of the aminooctose (northern) region, thus distinguishing them from lincomycin and clindamycin. Also provided are methods for preparing the lincosamide compounds, pharmaceutical compositions comprising the lincosamide compounds, and methods of treating infectious diseases using the disclosed lincosamide compounds.